PARP inhibitors in ovarian cancer therapy. Prospects in Pharmaceutical Sciences, [S. l.], v. 22, n. 2, p. 71–74, 2024. DOI: 10.56782/pps.185. Disponível em: https://prospects.wum.edu.pl/index.php/pps/article/view/185. Acesso em: 9 nov. 2026.